IP Library › Assignment 051666/0768
Patent Assignment
Reel/Frame 051666/0768

Conversion

Recorded: 2020-01-22 Pages: 3
Assignor
SUCAMPO AG
Executed: 2019-12-10
Assignee
SUCAMPO GMBH
BAARERSTRASSE 75, ZUG, 6300, SWITZERLAND
Covered Properties (4)
Method for Treating Gastrointestinal Disorder
Patent: 8,748,481 →
Application: 11/216,012 →
Publication: US 2006/0063830
Soft-Gelatin Capsule Formulation
Patent: 8,026,393 →
Application: 11/656,476 →
Publication: US 2007/0172523
Soft-Gelatin Capsule Formulation
Patent: 8,338,639 →
Application: 13/210,556 →
Publication: US 2011/0300211
Soft-Gelatin Capsule Formulation
Patent: 8,779,187 →
Application: 13/679,005 →
Publication: US 2013/0078303
Related Assignments (13)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 23, 2020
From: HASHITERA, YUKIKO; HIRATA, RYU; HARADA, YASUHIRO
To: R-TECH UENO, LTD.
Reel/Frame 051599/0086 →
Partial Assignment Jan 23, 2020
From: R-TECH UENO, LTD.
To: SUCAMPO AG
Reel/Frame 051681/0987 →
Assignment of Assignor's Interest Jan 23, 2020
From: UENO, RYUJI
To: R-TECH UENO, LTD.
Reel/Frame 051599/0266 →
Conversion Jan 27, 2020
From: SUCAMPO AG
To: SUCAMPO GMBH
Reel/Frame 051708/0596 →
Security Interest Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Notice of Grant of Security Interest in Intellectual Property Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Security Interest Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Security Interests in Patents at Reel 060389/Frame 0913 Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Release of Patent Security Interests Recorded at Reel 060434, Frame 0536 Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
Reel/Frame 065601/0347 →
Security Interest Aug 1, 2025
From: STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 071913/0691 →
Release of Security Interest Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 072324/0740 →
Merger and Change of Name Aug 26, 2025
From: R-TECH UENO, LTD.; SUCAMPO PHARMA, LLC
To: SUCAMPO PHARMA, LLC
Reel/Frame 072124/0659 →
Security Interest Oct 28, 2025
From: STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 072700/0001 →